Form 4: Progyny CEO Acquires 209,500 Shares in Open Market Transaction

Progyny's CEO, Peter Anevski, purchased 209,500 shares of common stock at a weighted average price of $14.4825 per share on December 23, 2024.

Summary

• Peter Anevski, the CEO of Progyny, Inc., acquired 209,500 shares of the company's common stock on December 23, 2024.
• The shares were purchased at a weighted average price of $14.4825 per share.
• The transactions occurred in multiple trades with prices ranging from $14.30 to $14.61 per share.
• Following the transaction, Mr. Anevski directly owns 441,463 shares of Progyny common stock.
• Some of the shares are held indirectly through PECO ANEVSKI 2020 SD LLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as the CEO's purchase indicates confidence, but it's a routine transaction.

Positives

• The CEO's purchase of a significant number of shares could be seen as a positive signal of confidence in the company's future prospects.
• The purchase increases the CEO's direct stake in the company, aligning his interests with those of other shareholders.

Industry Context

This transaction is a routine disclosure of insider trading activity and does not indicate any specific trend in the fertility benefits industry.

Comparison to Industry Standards

• Insider trading activity is common across all publicly listed companies and this transaction is not unusual.
• The size of the transaction is significant but not unusual for a CEO of a company of this size.

Stakeholder Impact

• The share purchase may have a slightly positive impact on shareholder confidence.

Key Dates

Keywords

Progyny, CEO, Peter Anevski, share purchase, insider trading, common stock, SEC Form 4